BNP and NTproBNP Market Size, Share, Revenue, Trends And Drivers For 2024-2033

The Business Research Company's BNP And NTproBNP Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LONDON, GREATER LONDON, UK, August 23, 2024 /EINPresswire.com/ -- The global BNP and NTproBNP market is experiencing rapid growth, expanding from $1.77 billion in 2023 to $2 billion in 2024, reflecting a compound annual growth rate (CAGR) of 13.2%. Despite recent challenges, the market is projected to reach $3.15 billion by 2028, growing at a CAGR of 12.1%. This growth is driven by factors including the increasing cardiovascular disease burden, integration into point-of-care testing, expanding applications in various medical conditions, personalized medicine approaches, and advancements in telemedicine and remote monitoring.

Aging Population Drives BNP and NTproBNP Market Growth
The aging global population is a crucial factor propelling the BNP and NTproBNP market. As the elderly population grows, the demand for diagnostic tools that effectively manage heart failure increases. BNP and NTproBNP biomarkers are vital for diagnosing and managing heart failure in older adults, providing essential insights into cardiac function. According to the World Health Organization, by 2030, 1 in 6 individuals globally will be 60 or older, with the number of elderly people expected to reach 2.1 billion by 2050. This demographic shift is fueling the demand for BNP and NTproBNP tests, enhancing market growth.

Explore comprehensive insights into the global BNP and NTproBNP market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=10673&type=smp

Major Players and Market Trends
Key players in the BNP and NTproBNP market include Abbott Laboratories, Gentian Diagnostics ASA, Siemens AG, PerkinElmer Inc., Biomerieux SA, and Quidel Corporation, among others. These companies are focusing on rapid screening bioassays to stay competitive. For example, Mindray Medical International Limited recently launched high-sensitivity troponin I (hs-cTnI) and NT-proBNP assays to enhance cardiovascular disease diagnostics. Additionally, Beckman Coulter secured exclusive rights for BNP assays through an agreement with Quidel Corporation, demonstrating a strategic move to strengthen its market position.

Segments
• By Type: BNP (Brain Natriuretic Peptide), NT-proBNP (N-terminal Pro–B-Type Natriuretic Peptide)
• By Location Of Testing: Point Of Care Testing, Laboratory Testing
• By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Other Applications

Geographical Insights: Asia-Pacific Leading the Market
In 2023, Asia-Pacific was the largest market for BNP and NTproBNP, and it continues to play a significant role. North America is anticipated to be the fastest-growing region during the forecast period, driven by technological advancements and increasing healthcare investments.

Access the complete report for an in-depth analysis of the global BNP and NTproBNP market: https://www.thebusinessresearchcompany.com/report/bnp-and-ntprobnp-global-market-report

BNP And NTproBNP Global Market Report 2024 from The Business Research Company covers the following information:
•Market size data for the forecast period: Historical and Future
•Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The BNP And NTproBNP Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on bnp and ntprobnp market size, bnp and ntprobnp market drivers and trends, bnp and ntprobnp market major players, bnp and ntprobnp competitors' revenues, bnp and ntprobnp market positioning, and bnp and ntprobnp market growth across geographies. The bnp and ntprobnp market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Cardiac Biomarkers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Cardiac Marker Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

Health Care Social Media Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/health-care-social-media-global-market-report

About The Business Research Company?
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube